The Japan dry eye disease market is forecasted to register a CAGR of 5.07% over the estimated period. The market growth of the country is reinforced by key drivers such as significant innovations in the medical field, the surging prevalence of dry eye disease, and increased research and development initiatives. While the base year considered for the market study is 2020, the projected years are from 2021 to 2026.
JAPAN DRY EYE DISEASE MARKET FORECAST 2021-2026
Japan Dry Eye Disease Market by Type (Otc, Prescription) Market by Product (Anti-inflammatory Drugs, Artificial Tears, Punctal Plugs, Secretagogues, Other Products) Market by Distribution Channel (Hospital Pharmacies, Independent Pharmacies and Drug Stores, Online Pharmacies)
The Japan dry eye disease market is forecasted to register a CAGR of 5.07% over the estimated period. The market growth of the country is reinforced by key drivers such as significant innovations in the medical field, the surging prevalence of dry eye disease, and increased research and development initiatives. While the base year considered for the market study is 2020, the projected years are from 2021 to 2026.
To learn more about this report, request a free sample copy
As a majorly innovation-driven nation across the medical field, Japan’s growth is anticipated to be consistent, owing to increased willingness and awareness in terms of enhancing the healthcare industry. As per the two cross-sectional population-based studies analyzing the epidemiological perspective of dry eye disease in Japan, the condition’s incidence among the Japanese population was considerably high, compared to reports from other nations.
Conversely, according to the article titled “medical treatment for dry eye in Japan,” sodium hyaluronate ophthalmic solutions, in combination with preservative-free artificial ophthalmic solutions, have been utilized for the treatment of dry eyes for several years. The same study also reported that an increased number of studies had evaluated the burden of the expenditure associated with dry eye disease in the country. Therefore, these factors are set to influence the dry eye disease market in Japan during the forecasting years.
Johnson & Johnson, headquartered in the United States, manufactures consumer healthcare products, medical devices, as well as pharmaceuticals. Its consumer goods constitute baby care products like powder blossoms, soap blossoms, skincare wipes, oils, creams, milk lotions, hair oils, shampoos, and gift boxes for babies. The company’s medical products include bleeding management, infection prevention, arrhythmias, cardiovascular disease, diabetes care products, and others.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- COUNTRY SNAPSHOT
- COUNTRY ANALYSIS
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY ANALYTICS
- IMPACT OF COVID-19 ON DRY EYE DISEASE MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRY
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- MARKET BY TYPE
- OTC
- PRESCRIPTION
- MARKET BY PRODUCT
- ANTI-INFLAMMATORY DRUGS
- CYCLOSPORINE
- CORTICOSTEROID
- OTHER ANTI-INFLAMMATORY DRUGS
- ARTIFICIAL TEARS
- PUNCTAL PLUGS
- SECRETAGOGUES
- OTHER PRODUCTS
- ANTI-INFLAMMATORY DRUGS
- MARKET BY DISTRIBUTION CHANNEL
- HOSPITAL PHARMACIES
- INDEPENDENT PHARMACIES AND DRUG STORES
- ONLINE PHARMACIES
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
- COMPANY PROFILES
- ALLERGAN PLC (ACQUIRED BY ABBVIE)
- BAUSCH HEALTH COMPANIES INC
- JOHNSON & JOHNSON
- NOVARTIS AG
- OTSUKA HOLDINGS CO LTD
- SANTEN PHARMACEUTICAL CO LTD
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – DRY EYE DISEASE
TABLE 2: JAPAN DRY EYE DISEASE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: JAPAN DRY EYE DISEASE MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 4: JAPAN DRY EYE DISEASE MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: JAPAN DRY EYE DISEASE MARKET, BY PRODUCT, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 6: JAPAN ANTI-INFLAMMATORY DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: JAPAN ANTI-INFLAMMATORY DRUGS MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 8: JAPAN DRY EYE DISEASE MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: JAPAN DRY EYE DISEASE MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 10: LIST OF MERGERS & ACQUISITIONS
TABLE 11: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 12: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 13: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCES ANALYSIS
FIGURE 2: OPPORTUNITY MATRIX
FIGURE 3: VENDOR LANDSCAPE
FIGURE 4: JAPAN DRY EYE DISEASE MARKET, BY TYPE, IN 2020
FIGURE 5: JAPAN DRY EYE DISEASE MARKET, BY OTC, 2021-2026 (IN $ MILLION)
FIGURE 6: JAPAN DRY EYE DISEASE MARKET, BY PRESCRIPTION, 2021-2026 (IN $ MILLION)
FIGURE 7: JAPAN DRY EYE DISEASE MARKET, BY PRODUCT, IN 2020
FIGURE 8: JAPAN DRY EYE DISEASE MARKET, BY ANTI-INFLAMMATORY DRUGS, 2021-2026 (IN $ MILLION)
FIGURE 9: JAPAN ANTI-INFLAMMATORY DRUGS MARKET, BY CYCLOSPORINE, 2021-2026 (IN $ MILLION)
FIGURE 10: JAPAN ANTI-INFLAMMATORY DRUGS MARKET, BY CORTICOSTEROID, 2021-2026 (IN $ MILLION)
FIGURE 11: JAPAN ANTI-INFLAMMATORY DRUGS MARKET, BY OTHER ANTI-INFLAMMATORY DRUGS, 2021-2026 (IN $ MILLION)
FIGURE 12: JAPAN DRY EYE DISEASE MARKET, BY ARTIFICIAL TEARS, 2021-2026 (IN $ MILLION)
FIGURE 13: JAPAN DRY EYE DISEASE MARKET, BY PUNCTAL PLUGS, 2021-2026 (IN $ MILLION)
FIGURE 14: JAPAN DRY EYE DISEASE MARKET, BY SECRETAGOGUES, 2021-2026 (IN $ MILLION)
FIGURE 15: JAPAN DRY EYE DISEASE MARKET, BY OTHER PRODUCTS, 2021-2026 (IN $ MILLION)
FIGURE 16: JAPAN DRY EYE DISEASE MARKET, BY DISTRIBUTION CHANNEL, IN 2020
FIGURE 17: JAPAN DRY EYE DISEASE MARKET, BY HOSPITAL PHARMACIES, 2021-2026 (IN $ MILLION)
FIGURE 18: JAPAN DRY EYE DISEASE MARKET, BY INDEPENDENT PHARMACIES AND DRUG STORES, 2021-2026 (IN $ MILLION)
FIGURE 19: JAPAN DRY EYE DISEASE MARKET, BY ONLINE PHARMACIES, 2021-2026 (IN $ MILLION)
- MARKET BY TYPE
- OTC
- PRESCRIPTION
- MARKET BY PRODUCT
- ANTI-INFLAMMATORY DRUGS
- CYCLOSPORINE
- CORTICOSTEROID
- OTHER ANTI-INFLAMMATORY DRUGS
- ARTIFICIAL TEARS
- PUNCTAL PLUGS
- SECRETAGOGUES
- OTHER PRODUCTS
- ANTI-INFLAMMATORY DRUGS
- MARKET BY DISTRIBUTION CHANNEL
- HOSPITAL PHARMACIES
- INDEPENDENT PHARMACIES AND DRUG STORES
- ONLINE PHARMACIES
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.